《世界卫生组织结核病整合指南模块3:诊断一一结核感染检测》解读

Interpretation of WHO consolidated guidelines on tuberculosis:Module 3:diagnosis:tests for tuberculosis infection

2022年9月30日,世界卫生组织(World Health Organization,WHO)发布WHO consolidated guidelines on tuberculosis:Module 3:diagnosis:tests for tuberculosis infection。该指南基于循证医学证据对不同结核分枝杆菌感染诊断技术的综合表现进行了系统评估,并首次增加了针对结核分枝杆菌抗原皮肤试验用于结核分枝杆菌感染诊断的推荐意见。笔者对该指南的编制过程及其形成的3个核心推荐意见加以解读,希望能够为我国结核分枝杆菌感染检测和控制工作提供基于循证医学的证据和参考。

On September 30,2022,the World Health Organization(WHO)published the WHO consolidated guidelines on tuberculosis:Module 3:diagnosis:tests for tuberculosis infection.The medical evidence-based guideline systematically evaluated the performance of different tests and recommended using of Mycobacterium tuberculosis antigen-based skin tests for the diagnosis of tuberculosis infection for the first time.The author now introduces the development of the new guideline and interprets the three key recommendations hoping to provide evidence-based reference for tuberculosis infection test and control.